Percutaneous ablation for localised kidney tumours
A recent study reported in European Urology by investigators at [...]
ICR cancer drug programme aims to deliver a step change in cancer treatment
The world's first 'Darwinian' cancer drug programme was launched by [...]
Avelumab plus axitinib granted FDA approval for advanced kidney cancer
The Food and Drug Administration (FDA) in the United States [...]
Percutaneous cryoablation for stage T1b tumours
A recent study published in Cardiovascular and Interventional Radiology this [...]
PD-1, PD-L1 and PD-L2 levels differ between patients
In a recent study, published in BMC Cancer last month, [...]
Effect of treatment delay on outcomes in metastatic kidney cancer
A recent study published in Science Direct followed patients with [...]
Clinical characteristics and genomic alterations associated with outcome in chromophobe RCC
A recent study by researchers in New York, USA, and [...]
Advances in systemic treatments for kidney cancer
In this video interview, Professor Jens Bedke, Professor of Urology [...]
CAR can be used to indicate survival in kidney cancer patients
A recent study with Japanese patients, published in Urologic Oncology [...]
Savolitinib shows promise in first-in-human phase 1 study in solid tumours
Results from a first-in-human phase 1 study of savolitinib in [...]
